Literature DB >> 2988376

Immunologic response of sheep to inactivated and virulent bluetongue virus.

J L Stott, T L Barber, B I Osburn.   

Abstract

Humoral and cellular immune responses of sheep to inactivated and virulent bluetongue virus (BTV) were studied. All sheep inoculated with inactivated BTV developed BTV group-specific nonneutralizing antibodies, as determined by agar-gel immunodiffusion. The development of group-specific, nonneutralizing, complement-fixing antibodies was variable and appeared to be dependent on immunizing BTV serotype, sheep breed, and individual variation. Virus-neutralizing antibodies were never detected after inoculation with the inactivated BTV. In vitro lymphocyte stimulation to BTV soluble antigen was observed with cells from all inoculated Warhill sheep and with cells from 1 of 3 inoculated Suffolk cross sheep. Complement-fixation titers did not appear to correlate with the degree of protection observed, ie, duration of postchallenge-exposure viremia. The development of postchallenge-exposure neutralizing antibody titer was inversely correlated to protective immunity. The development of a response to BTV antigen in the lymphocyte-stimulation test associated most closely with protection. Warhill sheep were afforded better protection, by inoculation with inactivated BTV, to live virus challenge exposure than were the Suffolk cross sheep. Approximately 30% of the inoculated Suffolk cross sheep responded to challenge exposure with intensified clinical signs of blue-tongue, compared with the challenge-exposed control sheep of the same breed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988376

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  13 in total

1.  Immune responses and protective efficacy of binary ethylenimine (BEI)-inactivated bluetongue virus vaccines in sheep.

Authors:  M A Ramakrishnan; A B Pandey; K P Singh; R Singh; S Nandi; M L Mehrotra
Journal:  Vet Res Commun       Date:  2006-11       Impact factor: 2.459

Review 2.  Prospects for improved bluetongue vaccines.

Authors:  Polly Roy; Mark Boyce; Robert Noad
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

3.  Genome segment reassortment between two serotypes of bluetongue virus in a natural host.

Authors:  J L Stott; R D Oberst; M B Channell; B I Osburn
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

Review 4.  Technical transformation of biodefense vaccines.

Authors:  Shan Lu; Shixia Wang
Journal:  Vaccine       Date:  2009-11-05       Impact factor: 3.641

5.  Evaluation of the immunogenicity of an experimental subunit vaccine that allows differentiation between infected and vaccinated animals against bluetongue virus serotype 8 in cattle.

Authors:  Jenna Anderson; Sara Hägglund; Emmanuel Bréard; Loic Comtet; Karin Lövgren Bengtsson; John Pringle; Stéphan Zientara; Jean Francois Valarcher
Journal:  Clin Vaccine Immunol       Date:  2013-05-29

6.  Characterization of the immune response induced by a commercially available inactivated bluetongue virus serotype 1 vaccine in sheep.

Authors:  Ana Cristina Pérez de Diego; Pedro José Sánchez-Cordón; Ana Isabel de las Heras; José Manuel Sánchez-Vizcaíno
Journal:  ScientificWorldJournal       Date:  2012-04-24

7.  Oncolytic bluetongue viruses: promise, progress, and perspectives.

Authors:  Joseph K-K Li
Journal:  Front Microbiol       Date:  2011-03-16       Impact factor: 5.640

8.  Recall T cell responses to bluetongue virus produce a narrowing of the T cell repertoire.

Authors:  José-Manuel Rojas; Teresa Rodríguez-Calvo; Noemí Sevilla
Journal:  Vet Res       Date:  2017-06-29       Impact factor: 3.683

9.  Protective Efficacy in Sheep of Adenovirus-Vectored Vaccines against Bluetongue Virus Is Associated with Specific T Cell Responses.

Authors:  Verónica Martín; Elena Pascual; Miguel Avia; Lourdes Peña; Félix Valcárcel; Noemí Sevilla
Journal:  PLoS One       Date:  2015-11-30       Impact factor: 3.240

10.  Ovine and murine T cell epitopes from the non-structural protein 1 (NS1) of bluetongue virus serotype 8 (BTV-8) are shared among viral serotypes.

Authors:  José M Rojas; Lourdes Peña; Verónica Martín; Noemí Sevilla
Journal:  Vet Res       Date:  2014-03-12       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.